- Home
- TAK vs CTVA Comparison
TAK vs CTVA Comparison
Compare TAK & CTVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAK
- CTVA
- Stock Information
- Founded
- TAK 1781
- CTVA 2018
- Country
- TAK Japan
- CTVA United States
- Employees
- TAK N/A
- CTVA N/A
- Industry
- TAK Biotechnology: Pharmaceutical Preparations
- CTVA Farming/Seeds/Milling
- Sector
- TAK Health Care
- CTVA Consumer Staples
- Exchange
- TAK Nasdaq
- CTVA Nasdaq
- Market Cap
- TAK 43.9B
- CTVA 41.1B
- IPO Year
- TAK N/A
- CTVA N/A
- Fundamental
- Price
- TAK $13.63
- CTVA $55.19
- Analyst Decision
- TAK
- CTVA Buy
- Analyst Count
- TAK 0
- CTVA 20
- Target Price
- TAK N/A
- CTVA $63.50
- AVG Volume (30 Days)
- TAK 1.3M
- CTVA 3.3M
- Earning Date
- TAK 10-31-2024
- CTVA 11-06-2024
- Dividend Yield
- TAK 4.65%
- CTVA 1.23%
- EPS Growth
- TAK 49.73
- CTVA N/A
- EPS
- TAK 1.27
- CTVA 0.98
- Revenue
- TAK $31,732,209,416.00
- CTVA $16,637,000,000.00
- Revenue This Year
- TAK $4.41
- CTVA $1.61
- Revenue Next Year
- TAK $1.09
- CTVA $4.04
- P/E Ratio
- TAK $21.56
- CTVA $58.32
- Revenue Growth
- TAK 9.43
- CTVA N/A
- 52 Week Low
- TAK $12.58
- CTVA $43.89
- 52 Week High
- TAK $15.08
- CTVA $63.75
- Technical
- Relative Strength Index (RSI)
- TAK 39.22
- CTVA 31.64
- Support Level
- TAK $13.46
- CTVA $57.00
- Resistance Level
- TAK $13.75
- CTVA $59.54
- Average True Range (ATR)
- TAK 0.16
- CTVA 1.33
- MACD
- TAK -0.01
- CTVA -0.66
- Stochastic Oscillator
- TAK 21.15
- CTVA 0.06
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
About CTVA Corteva Inc.
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva operates globally, but around half of revenue comes from North America.